Michel Demaré

Accessibility help Skip to navigation Skip to content Skip to footer

Sunday, 14 April, 2024

Executive Pay
Proxy advisers inflict ‘serious harm’ to UK, says AstraZeneca chair
Michel Demaré in FT hits out at ISS and Glass Lewis for applying ‘double standards’ after they opposed CEO pay package
Sunday, 14 April, 2024

Executive Pay
AstraZeneca chair: UK business needs a level playing field to compete
Double standards over pay do serious harm to our competitiveness in the war for talent
Thursday, 4 May, 2023

AstraZeneca PLC
AstraZeneca chair says it is paying CEO enough to ward off US rivals
Drugmaker’s chief executive Pascal Soriot had talks last year about a role with US group Biogen
Monday, 8 May, 2017

European companies
Syngenta deal will ‘drive modernisation’ of Chinese farming
Tie-up with ChemChina will boost country’s agribusiness, says chairman of Swiss group